Moslehi, Javid J.

Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis

Ma, P., Liu, J., Qin, J., Lai, L., Heo, G. S., Luehmann, H., Sultan, D., Bredemeyer, A., Bajapa, G., Feng, G., et al. (2024) · Circulation

Cancer Immunotherapy and BiomarkersViral Infections and Immunology Research

Cited by 187

Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated Myocarditis: A Narrative Review

Lehmann, L. H., Cautela, J., Palaskas, N., Baik, A. H., Meijers, W. C., Allenbach, Y., Alexandre, J., Rassaf, T., Müller, O. J., Aras, M., et al. (2021) · JAMA Cardiology

Cancer Immunotherapy and BiomarkersViral Infections and Immunology Research

Cited by 178

A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis

Johnson, D. B., McDonnell, W. J., Gonzalez-Ericsson, P. I., Al-Rohil, R. N., Mobley, B. C., Salem, J.-E., Wang, D. Y., Sanchez, V., Wang, Y., Chastain, C. A., et al. (2019) · Nature Medicine

Cancer Immunotherapy and BiomarkersAutoimmune Neurological Disorders and Treatments

Cited by 176

Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis

Lehmann, L. H., Heckmann, M. B., Bailly, G., Finke, D., Procureur, A., Power, J. R., Stein, F., Bretagne, M., Ederhy, S., Fenioux, C., et al. (2023) · Circulation

Cancer Immunotherapy and BiomarkersViral Infections and Immunology Research

Cited by 165

A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo

Minamishima, Y. A., Moslehi, J., Padera, R. F., Bronson, R. T., Liao, R., & Kaelin, W. G. (2009) · Molecular and Cellular Biology

Cancer, Hypoxia, and MetabolismErythropoietin and Anemia Treatment

Cited by 161

Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective

Gougis, P., Jochum, F., Abbar, B., Dumas, E., Bihan, K., Lebrun-Vignes, B., Moslehi, J., Spano, J.-P., Laas, E., Hotton, J., et al. (2024) · eClinicalMedicine

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 161

Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies

Baik, A. H., Oluwole, O. O., Johnson, D. B., Shah, N., Salem, J.-E., Tsai, K. K., & Moslehi, J. J. (2021) · Circulation Research

Chemotherapy-induced cardiotoxicity and mitigationCancer Immunotherapy and Biomarkers

Cited by 138

Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database

Nguyen, L. S., Cooper, L. T., Kerneis, M., Funck-Brentano, C., Silvain, J., Brechot, N., Hekimian, G., Ammirati, E., Ben M’Barek, B., Redheuil, A., et al. (2022) · Nature Communications

Pharmacovigilance and Adverse Drug ReactionsViral Infections and Immunology Research

Cited by 136

Immune checkpoint inhibitor-associated primary adrenal insufficiency: WHO VigiBase report analysis

Grouthier, V., Lebrun-Vignes, B., Moey, M., Johnson, D. B., Moslehi, J. J., Salem, J.-E., & Bachelot, A. (2020) · The Oncologist

Cancer Immunotherapy and BiomarkersAdrenal Hormones and Disorders

Cited by 126

Harnessing big data to characterize immune-related adverse events

Jing, Y., Yang, J., Johnson, D. B., Moslehi, J. J., & Han, L. (2022) · Nature Reviews Clinical Oncology

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 125

Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research

Johnson, D. B., Reynolds, K. L., Sullivan, R. J., Balko, J. M., Patrinely, J. R., Cappelli, L. C., Naidoo, J., & Moslehi, J. J. (2020) · The Lancet Oncology

Cancer Immunotherapy and BiomarkersImmunotoxicology and immune responses

Cited by 118

Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute—Cancer Therapy Evaluation Program

Naqash, A. R., Moey, M. Y. Y., Cherie Tan, X.-W., Laharwal, M., Hill, V., Moka, N., Finnigan, S., Murray, J., Johnson, D. B., Moslehi, J. J., et al. (2022) · Journal of Clinical Oncology

Cancer Immunotherapy and BiomarkersChemotherapy-induced cardiotoxicity and mitigation

Cited by 87

Sex-Specific Cardiovascular Risks of Cancer and Its Therapies

Wilcox, N. S., Rotz, S. J., Mullen, M., Song, E. J., Ky Hamilton, B., Moslehi, J., Armenian, S. H., Wu, J. C., Rhee, J.-W., & Ky, B. (2022) · Circulation Research

Chemotherapy-induced cardiotoxicity and mitigationCardiac tumors and thrombi

Cited by 86

Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis

Fenioux, C., Abbar, B., Boussouar, S., Bretagne, M., Power, J. R., Moslehi, J. J., Gougis, P., Amelin, D., Dechartres, A., Lehmann, L. H., et al. (2023) · Nature Medicine

Cancer Immunotherapy and BiomarkersMyasthenia Gravis and Thymoma

Cited by 83

Cancer-Drug Discovery and Cardiovascular Surveillance

Groarke, J. D., Cheng, S., & Moslehi, J. (2013) · New England Journal of Medicine

Chemotherapy-induced cardiotoxicity and mitigationChronic Myeloid Leukemia Treatments

Cited by 83

Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor–Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial

Rini, B. I., Moslehi, J. J., Bonaca, M., Schmidinger, M., Albiges, L., Choueiri, T. K., Motzer, R. J., Atkins, M. B., Haanen, J., Mariani, M., et al. (2022) · Journal of Clinical Oncology

Renal cell carcinoma treatmentChemotherapy-induced cardiotoxicity and mitigation

Cited by 77

Demographic Factors Associated with Toxicity in Patients Treated with Anti-Programmed Cell Death-1 Therapy

Shah, K. P., Song, H., Ye, F., Moslehi, J. J., Balko, J. M., Salem, J.-E., & Johnson, D. B. (2020) · Cancer Immunology Research

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 64

Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligand

Patrinely, J. R., Young, A. C., Quach, H., Williams, G. R., Ye, F., Fan, R., Horn, L., Beckermann, K. E., Gillaspie, E. A., Sosman, J. A., et al. (2020) · European Journal of Cancer

Cancer Immunotherapy and BiomarkersCancer survivorship and care

Cited by 61

Immune Checkpoint Inhibitor Myocarditis Treatment Strategies and Future Directions

Moslehi, J., & Salem, J.-E. (2022) · JACC: CardioOncology

Cancer Immunotherapy and BiomarkersChemotherapy-induced cardiotoxicity and mitigation

Cited by 59

Autoimmune Myocarditis, Old Dogs and New Tricks.

Won, T., Song, E. J., Kalinoski, H. M., Moslehi, J. J., & Čiháková, D. (2024) · Circulation Research

Viral Infections and Immunology ResearchCardiac Fibrosis and Remodeling

Cited by 51

Treatment of erythropoietin deficiency in mice with systemically administered siRNA

Querbes, W., Bogorad, R. L., Moslehi, J., Wong, J., Chan, A. Y., Bulgakova, E., Kuchimanchi, S., Akinc, A., Fitzgerald, K., Koteliansky, V., et al. (2012) · Blood

Erythropoietin and Anemia TreatmentIron Metabolism and Disorders

Cited by 45

Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis

Power, J. R., Alexandre, J., Choudhary, A., Ozbay, B., Hayek, S. S., Asnani, A., Tamura, Y., Aras, M., Cautela, J., Thuny, F., et al. (2022) · Archives of Cardiovascular Diseases

Viral Infections and Immunology ResearchCancer Immunotherapy and Biomarkers

Cited by 43

The 2019 Nobel Prize honors fundamental discoveries in hypoxia response

Moslehi, J., & Rathmell, W. K. (2019) · Journal of Clinical Investigation

Cancer, Hypoxia, and MetabolismErythropoietin and Anemia Treatment

Cited by 25

RNA-Sequencing Reveals a Distinct Transcriptomic Signature for Giant Cell Myocarditis and Identifies Novel Druggable Targets

Amancherla, K., Qin, J., Wang, Y., Axelrod, M. L., Balko, J. M., Schlendorf, K. H., Hoffman, R. D., Xu, Y., Lindenfeld, J., & Moslehi, J. (2021) · Circulation Research

Viral Infections and Immunology ResearchVasculitis and related conditions

Cited by 12